Dataset Information

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

ABSTRACT: The present study aimed to retrospectively analyze the survival outcomes and prognostic factors for patients with nasopharyngeal carcinoma (NPC) receiving intensity-modulated radiotherapy (IMRT).Clinical data was collected from 691 patients with NPC receiving IMRT from January 2009 to August 2015. A survival analysis was performed and prognostic factors were analyzed using the Kaplan-Meier method, the Cox proportional hazards regression model, and the log-rank test.The median follow-up time was 62.8 months. Sixty-three patients experienced relapse, 44 cases (70%) of which occurred within 3 years. Six cases (9.5%) remained in remission for over 5 years. Seventy-two patients developed metastasis, 63 cases (87.5%) of which occurred within 3 years and only 1 case occurred after 5 years (1.3%). Five-year disease special survival (DSS), progression free survival, locoregional recurrence free survival, and distant metastasis free survival were 86.5%, 82.5%, 90.7%, and 89.4%, respectively in patients with NPC. Patients with stage III NPC with and without induction chemotherapy had 5-year DSS rates of 95.8% and 89.3%, respectively (P?=?.00). Patients with stage IVa NPC with and without induction chemotherapy had 5-year DSS rates of 73.1% and 68.9%, respectively (P?=?.04). The 5-year DSS rates of patients with stage III with or without concurrent chemotherapy were 92.8% and 85.5%, respectively (P?=?.04). The 5-year DSS rates of patients with stage IV with or without concurrent chemotherapy were 72.7% and 53.0% (P?=?.02).IMRT improves the survival rate of patients with NPC. Recurrence and metastasis mainly occur within 2 to 3 years after radiotherapy. Induction and concurrent chemotherapy improve the 5-year DSS of patients with locally advanced NPC.

SUBMITTER: Wu S

PROVIDER: S-EPMC7386990 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

Wu Shihai S Quan Rencui R Han Ling L Zhang Huaqing H Zhang Baozhu B Xu Gang G Li Xianming X

Medicine 20200701 30

The present study aimed to retrospectively analyze the survival outcomes and prognostic factors for patients with nasopharyngeal carcinoma (NPC) receiving intensity-modulated radiotherapy (IMRT).Clinical data was collected from 691 patients with NPC receiving IMRT from January 2009 to August 2015. A survival analysis was performed and prognostic factors were analyzed using the Kaplan-Meier method, the Cox proportional hazards regression model, and the log-rank test.The median follow-up time was ...[more]

PMID: 32791728

Similar Datasets

Project description:PurposeNutritional status and haematological parameters are related to the prognosis of patients treated with radiotherapy, but the correlation between adaptive radiotherapy (ART) and haematological indicators has never been reported. This study explores the influence of ART on the change in haematological indicators and provides a theoretical basis for the use of ART in patients with nasopharyngeal carcinoma (NPC).Patients and methodsWe retrospectively analysed 122 patients with NPC from January 2014 to December 2015. Patients in two treatment groups were matched using the propensity score matching method at a ratio of 1:1. The data were analysed with the Kaplan-Meier method, log-rank tests, regression analyses and paired t tests.ResultsSignificant differences were detected for changes in the neutrophil-to-lymphocyte ratio (?NLR), circulating lymphocyte count (?CLC), circulating platelet count (?CPC), and circulating neutrophil granulocyte count (?CNC) during radiotherapy (P?=?0.002, P?<?0.001, and P?=?0.036, respectively) between the ART and non-ART groups. Differences in acute radiation injury to the parotid glands (PGs) (P?<?0.001), skin (P?<?0.001), and oral structures (P?<?0.001), ?weight (kg) (P?=?0.025), and ?weight (%) (P?=?0.030) were also significant between the two groups. According to univariate and multivariate analyses, ART (R?=?0.531, P?=?0.004), skin-related side effects (R?=?0.328, P?=?0.020), and clinical stage (R?=?-0.689, P?<?0.001) are influencing factors for the ?NLR in patients. ART is also the influencing factor for the ?CLC (R?=?2.108, P?<?0.001) and the only factor affecting the ?CPC (R?=?0.121, P?=?0.035). Based on subgroup analyses, for stage T1-2N0-3 disease, ?CLC was higher in patients in the ART group than in patients in the non-ART group (P?<?0.001, P?=?0.003, and P?=?0.003).ConclusionART ameliorates changes in haematological indexes (?NLR, ?CLC, and ?CPC) and reduces side effects to the skin and PGs and weight loss during radiotherapy in patients with NPC, and patients with stage T1-2 disease experience a greater benefit.

Dataset Information

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

Publications

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets